Leverette

Ethinylestradiol, the active ingredient in Leverette, is a combined oral contraceptive presented as a tablet formulation for oral use. It works together with levonorgestrel to prevent ovulation and is prescribed for women seeking reliable contraception and to regulate menstrual cycles as part of a monthly cycle regimen and provides additional benefits such as reduced menstrual bleeding.

GNH USA supplies Leverette as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with a focus on quality assurance and regulatory compliance.

Leverette, a combined oral contraceptive, is used within the reproductive health pathway to prevent unintended pregnancy.

Contraception: prevents unintended pregnancy by inhibiting ovulation and altering cervical mucus. Menstrual cycle regulation: helps achieve more predictable bleeding patterns and may reduce dysmenorrhea. Acne management: may improve acne symptoms associated with hormonal fluctuations.

Leverette may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea - Headache - Breast tenderness - Spotting or breakthrough bleeding

Serious or Rare Side Effects: - Deep vein thrombosis - Pulmonary embolism - Stroke - Severe allergic reaction (anaphylaxis)

Before prescribing Leverette, clinicians should consider several safety measures.

Pregnancy testing: confirm non‑pregnant status before initiating therapy. Smoking: avoid use in women over 35 who smoke due to increased cardiovascular risk. Medical history: assess for history of thromboembolic disorders, hypertension, or liver disease. Medication review: evaluate concurrent use of enzyme‑inducing drugs that may reduce efficacy. Store at ambient temperature: keep tablets in original container, protect from moisture and heat.

Leverette can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Strong enzyme inducers (e.g., rifampin, carbamazepine) may markedly reduce contraceptive effectiveness. - Concurrent use with anticoagulants may increase the risk of thrombotic events. - Use with other estrogen‑containing products (e.g., hormone replacement therapy) may heighten estrogen‑related adverse effects.

Moderate Interactions (Monitor Closely): - Antifungal agents such as ketoconazole may increase plasma levels of hormonal components. - Certain antibiotics (e.g., tetracycline) may slightly reduce contraceptive efficacy. - Herbal supplements containing St. John’s Wort may decrease effectiveness.